1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prevention of mucositis with KGF in patients undergoing allogeneic stem cell transplantation
    Meeting Abstract

    Goldberg, J. D.; Zheng, J.; Castro-Malaspina, H.; Jakubowski, A. A.; Heller, G.; Van Den Brink, M. R. M.; Perales, M.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Association of germ-line variation with platinum-based chemotherapy response in patients (pts) with urothelial carcinoma (UC)
    Meeting Abstract

    Gallagher, D. J.; Joseph, V.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; Milowsky, M. I.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Combined inhibition of mTORC1 with temsirolimus and HER2 with neratinib: A phase I study in patients with metastatic HER2-amplified breast cancer
    Meeting Abstract

    Gajria, D.; King, T. A.; Pannu, H.; Sakr, R.; Seidman, A. D.; Syldor, A.; Patil, S.; Maybody, M.; Norton, L.; Rosen, N.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II multicenter evaluation of ARQ 197 monotherapy in patients with relapsed or refractory germ cell tumors (GCTs)
    Meeting Abstract

    Feldman, D. R.; Einhorn, L. H.; Quinn, D. I.; Horwich, A.; Loriot, Y.; Joffe, J. K.; Vaughn, D. J.; Flechon, A.; Hajdenberg, J.; Pande, A. U.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis
    Meeting Abstract

    Elkin, E. B.; Lowrance, W. T.; Denton, B.; Mirkin, J. N.; Eastham, J. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Primary dose reduction (PDR) of chemotherapy (chemo) in patients (Pts) older than age 65 with advanced cancer (Ca) and toxicity outcomes
    Meeting Abstract

    Gajra, A.; Hardt, M.; Tew, W. P.; Mohile, S. G.; Owusu, C.; Klepin, H. D.; Gross, C. P.; Lichtman, S. M.; Ramani, R.; Brown, J.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • TBCRC 019: An open-label, randomized, phase II trial of nanoparticle albumin-bound paclitaxel with or without the anti-death receptor 5 (DR5) monoclonal antibody tigatuzumab in patients with metastatic, triple-negative (ER, PR, and HER2-negative) breast cancer
    Meeting Abstract

    Forero-Torres, A.; Lin, N. U.; Liu, M. C.; Rugo, H. S.; Puhalla, S.; Nanda, R.; Mayer, I. A.; Storniolo, A. M.; Traina, T. A.; Hayes, D. F.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m(2) for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Lisa, D. M.; Agarwal, N.; Algazy, K. M.; Brockstein, B.; Langer, C. J.; Lim, D.; Mehra, R.; Rajan, S. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Open-label, sequential, ascending, multi-dose, phase I study of KW-2450 as monotherapy in subjects with previously treated advanced solid tumors
    Meeting Abstract

    Dickson, M. A.; LoRusso, P.; Sausville, E. A.; Rao, N.; Kobayashi, E.; Kurman, M. R.; Akinaga, S.; Schwartz, G. K.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A pilot study of vaccination with sialyl Lewis(a) (sLe(a))-keyhole limpet hemocyanin (KLH) conjugate plus the immunologic adjuvant QS-21 in metastatic breast cancer patients (pts)
    Meeting Abstract

    Diab, A.; Ragupathi, G.; Scholz, W. W.; Panageas, K.; Hudis, C.; Livingston, P. O.; Gilewski, T.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save